
Myeloperoxidase -463 G/A polymorphism is associated with lung cancer risk
Author(s) -
Shengqiang Zou,
Xin Pan,
Changsong Hua,
Min Wu,
Bin He,
Zhigang Chen
Publication year - 2018
Publication title -
journal of cancer research and therapeutics/journal of cancer research and therapeutics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.475
H-Index - 39
eISSN - 0973-1482
pISSN - 1998-4138
DOI - 10.4103/0973-1482.235341
Subject(s) - lung cancer , odds ratio , medicine , confidence interval , subgroup analysis , gastroenterology , myeloperoxidase , meta analysis , lung cancer susceptibility , oncology , genotype , single nucleotide polymorphism , biology , genetics , inflammation , gene
Several studies evaluated the association between myeloperoxidase (MPO) -463 G/A polymorphism and the risk of lung cancer. However, the results were not stable.